Nurix Therapeutics
Price & Volume
Stats
See moreOpen | $12.05 |
Previous Close | $12.17 |
Day Range | $12.02-$12.93 |
52W Range | $8.18-$26.62 |
Market Cap | $1.2B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $83.6M |
Revenue Growth (YoY) | -37.3% |
Gross Profit (12 Mos) | -$217.4M |
Diluted EPS | -$2.97 |
News
See moreYahoo Finance • 3 days ago
Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
Yahoo Finance • 10 days ago
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
Yahoo Finance • 17 days ago
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
Yahoo Finance • 22 days ago
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
